Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sensegain Group is a China-based asset management and private equity organization rather than a biotechnology, pharmaceutical, or healthcare operating company. Publicly available descriptions identify it as an investment group focused on private equity, venture capital, mergers and acquisitions, public-market value management, and related financial services. The firm appears to invest across multiple sectors including TMT, healthcare, clean energy, education, and advanced manufacturing, but it does not appear to develop therapeutics, diagnostics, or medical products itself. As a result, it is better classified as a financial sponsor with healthcare investment exposure than as a life sciences company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sensegain Group.